Literature DB >> 35088142

Primary versus delayed primary skin closure in operated patients due to perforated peptic ulcer disease: a randomized controlled clinical trial.

Arash Mohammadi Tofigh1, Shervan Family2.   

Abstract

PURPOSE: Perforated peptic ulcer (PPU) is a life-threatening complication of peptic ulcer disease. This condition is characterized by a dirty abdomen that predisposes to postoperative wound infection. Delayed primary skin closure is occasionally preferred over primary closure to reduce the risk of surgical site infection in dirty abdominal wounds. In primary skin closure, the skin is sutured immediately after surgery. Meanwhile, in delayed primary skin closure, the incision is left open, and sutured after 2-5 days. The current research aimed to compare the risk for surgical site infection, length of hospitalization, and mortality rate between primary versus delayed primary skin closure among patients who underwent surgery for PPU.
METHODS: This single-blind randomized clinical trial included 120 patients who were randomly allocated into the primary and delayed primary closure groups. A research assistant who was blinded to the study examined the wounds for surgical site infection based on the 1992 Center for Disease Control criteria. The outcomes were mortality rate and duration of hospitalization.
RESULTS: The delayed primary and primary closure groups did not significantly differ in terms of postsurgical wound infection occurring on the 3rd, 7th, 14th, and 30th days after surgery, mortality rate, and duration of hospitalization.
CONCLUSION: In patients who underwent surgery for PPU, delayed primary closure is not recommended over primary closure due to the risk of postoperative surgical site infection.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Delayed primary skin closure; Dirty abdominal wound; Perforated peptic ulcer disease; Primary skin closure; Surgical site infection

Mesh:

Year:  2022        PMID: 35088142     DOI: 10.1007/s00423-021-02405-4

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   2.895


  26 in total

Review 1.  Trends in perforated peptic ulcer: incidence, etiology, treatment, and prognosis.

Authors:  C Svanes
Journal:  World J Surg       Date:  2000-03       Impact factor: 3.352

2.  Evaluating an evidence-based bundle for preventing surgical site infection: a randomized trial.

Authors:  Thomas Anthony; Bryce W Murray; John T Sum-Ping; Fima Lenkovsky; Vadim D Vornik; Betty J Parker; Jackie E McFarlin; Kathleen Hartless; Sergio Huerta
Journal:  Arch Surg       Date:  2010-11-15

Review 3.  Systematic review comparing laparoscopic and open repair for perforated peptic ulcer.

Authors:  R Lunevicius; M Morkevicius
Journal:  Br J Surg       Date:  2005-10       Impact factor: 6.939

Review 4.  Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality.

Authors:  James Y Lau; Joseph Sung; Catherine Hill; Catherine Henderson; Colin W Howden; David C Metz
Journal:  Digestion       Date:  2011-04-14       Impact factor: 3.216

Review 5.  Systemic review and meta-analysis of randomized clinical trials comparing primary vs delayed primary skin closure in contaminated and dirty abdominal incisions.

Authors:  Aneel Bhangu; Prashant Singh; Jonathan Lundy; Douglas M Bowley
Journal:  JAMA Surg       Date:  2013-08       Impact factor: 14.766

6.  Impact of postdischarge surveillance on surgical site infection rates for several surgical procedures: results from the nosocomial surveillance network in The Netherlands.

Authors:  Judith Manniën; Jan C Wille; Ruud L M M Snoeren; Susan van den Hof
Journal:  Infect Control Hosp Epidemiol       Date:  2006-07-20       Impact factor: 3.254

Review 7.  Perforated peptic ulcer disease: a review of history and treatment.

Authors:  Mariëtta J O E Bertleff; Johan F Lange
Journal:  Dig Surg       Date:  2010-06-22       Impact factor: 2.588

8.  Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.

Authors:  J P Gisbert; J Legido; I García-Sanz; J M Pajares
Journal:  Dig Liver Dis       Date:  2004-02       Impact factor: 4.088

9.  Epidemiology of perforated peptic ulcer: age- and gender-adjusted analysis of incidence and mortality.

Authors:  Kenneth Thorsen; Jon Arne Søreide; Jan Terje Kvaløy; Tom Glomsaker; Kjetil Søreide
Journal:  World J Gastroenterol       Date:  2013-01-21       Impact factor: 5.742

10.  Trends in diagnosis and surgical management of patients with perforated peptic ulcer.

Authors:  Kenneth Thorsen; Tom B Glomsaker; Andreas von Meer; Kjetil Søreide; Jon Arne Søreide
Journal:  J Gastrointest Surg       Date:  2011-05-13       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.